Home > Pill Identifier > SENOKOT-S Oral Tablet

Pill Identifier Information of SENOKOT-S Oral Tablet

Drug Information

SENOKOT-S Oral Tablet

Imprint: P
Shape: C48348
Color: C48331
Ingredients: Docusate; sennosides, USP
Size: 10.00
Score: 1
Rxtty: SY
Author: Purdue Products LP
Inactive Ingredients: carnauba wax / silicon dioxide / croscarmellose sodium / anhydrous dibasic calcium phosphate / anhydrous lactose / d&c yellow no. 10 / fd&c yellow no. 6 / aluminum oxide / hypromellose / magnesium stearate / cellulose, microcrystalline / polyethylene glycol 8000 / sodium benzoate / stearic acid / tartaric acid / titanium dioxide>

Complete Information

  • INDICATIONS & USAGE

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredients (in each tablet)

    Docusate sodium         50mg

    Sennosides                      8.6mg

  • PURPOSE

    Purpose

    Stool softener

    Laxative

  • WHEN USING

    Uses

    • relieves occasional constipation (irregularity)
    • generally produces a bowel movement in 6-12 hours
  • WARNINGS

    Warnings

  • DO NOT USE

    Do not use

    • if you are now taking mineral oil, unless directed by adoctor
    • laxative products for longer than 1 week unless directedby a doctor
  • ASK DOCTOR

    Ask a doctor before use if you have

    • stomach pain
    • nausea
    • vomiting
    • noticed a sudden change in bowel habits that continues overa period of 2 weeks
  • STOP USE

    Stop using and ask a doctor if youhave rectal bleeding or fail to have a bowel movement after use ofa laxative. These may indicate a serious condition.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reachof children.

    In case ofoverdose, get medical help or contact a Poison Control Center rightaway.

  • DOSAGE & ADMINISTRATION

    Directions

    • take preferably at bedtime or as directed by a doctor
    agestartingdosagemaximumdosage
    adults and children
    12 years of age and over    		2 tablets oncea day4 tablets twicea day
    children 6 to under 12 years1 tablet once a day2 tablets twice a day
    children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
    children under 2 yearsask a doctorask a doctor
  • HOW SUPPLIED

    Other information

    • each tablet contains: calcium 7 mg, sodium 4 mg VERYLOW SODIUM
    • store at 25°C (77°F); excursions permitted between 15°-30°C(59°-86°F)
  • INACTIVE INGREDIENT

    Inactive ingredients

    Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Yellow#5 Lake*, FD&C Yellow #6 Lake, hypromellose, magnesium stearate,maltodextrin, microcrystalline cellulose, mineral oil, polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, starch, stearic acid,talc, titanium dioxide, triacetin

    ©2020

    Avrio Health L.P.

    A1023

  • PRINCIPAL DISPLAY PANEL

    Senokot-S 60 Tablets Label
    NDC: 67618-310-60

    60 Tablets Label

    Senokot-S 60 Tablets Leaflet
    NDC: 67618-310-60

    60 Tablets Leaflet

    Senokot-S 60 Tablets Carton
    NDC: 67618-310-60

    60 Tablets Carton

    Senokot-S 10 Tablets Carton
    NDC: 67618-310-01

    10 Tablets Carton Front
    10 Tablets Carton Back

    Senokot-S 100 Tablets Label
    NDC: 67618-310-10

    100 Tablets Label

    Senokot-S 100 Tablets Leaflet
    NDC: 67618-310-10

    100 Tablets Leaflet
  • INGREDIENTS AND APPEARANCE
    SENOKOT-S 
    standardized senna concentrate and docusate sodium tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67618-310
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
    FD&C YELLOW NO. 5 (UNII: I753WB2F1M)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TALC (UNII: 7SEV7J4R1U)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    TRIACETIN (UNII: XHX3C3X673)  
    Product Characteristics
    ColorORANGEScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code P
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:67618-310-011 in 1 CARTON10/01/1974
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:67618-310-301 in 1 CARTON10/01/1974
    230 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    3NDC:67618-310-601 in 1 CARTON10/01/1974
    360 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    4NDC:67618-310-101 in 1 CARTON09/30/2026
    4100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00710/01/1974
    Labeler - Atlantis Consumer Healthcare, Inc. (118983925)
    Registrant - Atlantis Consumer Healthcare, Inc. (118983925)